Article Text

Download PDFPDF
Imatinib reduces bone marrow fibrosis and overwhelms the adverse prognostic impact of reticulin formation in patients with chronic myeloid leukaemia
  1. Eda Tanrikulu Simsek1,
  2. Ahmet Emre Eskazan2,
  3. Mahir Cengiz3,
  4. Muhlis Cem Ar2,
  5. Seda Ekizoglu4,
  6. Ayse Salihoglu2,
  7. Emine Gulturk2,
  8. Tugrul Elverdi2,
  9. Seniz Ongoren Aydin2,
  10. Ahu Senem Demiroz5,
  11. Ayse Nur Buyru4,
  12. Zafer Baslar2,
  13. Ugur Ozbek6,
  14. Burhan Ferhanoglu7,
  15. Yildiz Aydin2,
  16. Nukhet Tuzuner5,
  17. Teoman Soysal2
  1. 1Division of Medical Oncology, Department of Internal Medicine, Pendik Training and Research Hospital, Marmara University, Istanbul, Turkey
  2. 2Division of Hematology, Department of Internal Medicine, Cerrahpasa Faculty of Medicine, Istanbul University, Istanbul, Turkey
  3. 3Department of Internal Medicine, Cerrahpasa Faculty of Medicine, Istanbul University, Istanbul, Turkey
  4. 4Department of Medical Biology, Cerrahpasa Faculty of Medicine, Istanbul University, Istanbul, Turkey
  5. 5Department of Pathology, Cerrahpasa Faculty of Medicine, Istanbul University, Istanbul, Turkey
  6. 6Department of Genetics, Institute of Experimental Medicine (DETAE), Istanbul University, Istanbul, Turkey
  7. 7Division of Hematology, Department of Internal Medicine, Faculty of Medicine, Koc University, Istanbul, Turkey
  1. Correspondence to Dr Teoman Soysal, Division of Hematology, Department of Internal Medicine, Istanbul University, Cerrahpasa Faculty of Medicine, Fatih, Istanbul 34303, Turkey; teomansoysal{at}gmail.com

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.